Medicare Enrolled
Dr. Mansoor Javeed, M.D.
Hematology & Oncology · Folsom, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Javeed from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Javeed?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Javeed
Dr. Mansoor Javeed is a hematology & oncology specialist in Folsom, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Javeed performed 67,960 Medicare services across 1,067 unique beneficiaries.
Between the years covered by Open Payments, Dr. Javeed received a total of $16,496 from 85 pharmaceutical and/or device companies across 616 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Javeed is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 11% volume in CA
$16,496 industry payments
Medicare Practice Summary
Medicare Utilization ↗67,960
Medicare services
Top 11% in CA for hematology & oncology
1,067
Unique beneficiaries
$3
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,398 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Filgrastim injection (Nivestym) for white blood cells An injection of the biosimilar medication filgrastim-aafi (Nivestym) at a dose of 1 microgram. |
41,100 | $0 | $1 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
18,600 | $0 | $5 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,283 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,630 | $1 | $9 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
694 | $14 | $40 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
622 | $59 | $160 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
583 | $93 | $250 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
394 | $116 | $350 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
288 | $12 | $50 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
225 | $25 | $70 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
142 | $11 | $30 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
139 | $57 | $150 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
130 | $25 | $70 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
116 | $56 | $160 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
115 | $1 | $2 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
111 | $45 | $160 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
108 | $2 | $4 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 106 | $132 | $456 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
103 | $1 | $10 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
87 | $17 | $50 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
72 | $1 | $8 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
70 | $29 | $100 |
| New patient office visit, complex (60-74 min) | 68 | $176 | $450 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
46 | $33 | $110 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
45 | $28 | $70 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
32 | $145 | $310 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
28 | $22 | $50 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
23 | $124 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.8% high complexity
95.5% medium
2.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$16,496
Total received (2018-2024)
Avg $2,357/year across 7 years
Top 24% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
85
Companies
616
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,639 (64.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$4,137 (25.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,720 (10.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,598
2023
$2,896
2022
$2,136
2021
$2,377
2020
$1,493
2019
$3,310
2018
$1,686
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$254
Astellas Pharma US Inc
$200
AstraZeneca Pharmaceuticals LP
$192
ABBVIE INC.
$171
Merck Sharp & Dohme LLC
$145
Incyte Corporation
$129
Novartis Pharmaceuticals Corporation
$124
Genentech USA, Inc.
$119
SEAGEN INC.
$100
ARRAY BIOPHARMA INC
$99
E.R. Squibb & Sons, L.L.C.
$86
GlaxoSmithKline, LLC.
$82
Daiichi Sankyo Inc.
$79
Takeda Pharmaceuticals U.S.A., Inc.
$78
Regeneron Healthcare Solutions, Inc.
$68
Janssen Biotech, Inc.
$67
Alexion Pharmaceuticals, Inc.
$61
PUMA BIOTECHNOLOGY, INC.
$56
SOBI, INC
$42
GENZYME CORPORATION
$42
Agios Pharmaceuticals, Inc.
$35
Celgene Corporation
$32
TAIHO ONCOLOGY, INC.
$29
SERVIER PHARMACEUTICALS LLC
$28
Genmab U.S., Inc.
$27
Stemline Therapeutics Inc.
$26
Sumitomo Pharma America, Inc.
$23
Coherus Biosciences Inc.
$22
Fresenius Kabi USA, LLC
$22
SpringWorks Therapeutics, Inc.
$22
Kite Pharma, Inc.
$21
Deciphera Pharmaceuticals Inc.
$20
Gilead Sciences, Inc.
$20
SUN PHARMACEUTICAL INDUSTRIES INC.
$19
Mirati Therapeutics, Inc.
$18
Aveo Pharmaceuticals, Inc.
$15
Fennec Pharmaceuticals, Inc.
$14
Exelixis Inc.
$14
Top 3 companies account for 24.8% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$2,764
Genentech USA, Inc.
$1,234
Astellas Pharma US Inc
$1,026
AstraZeneca Pharmaceuticals LP
$825
Seagen Inc.
$746
Amgen Inc.
$741
PFIZER INC.
$740
Novartis Pharmaceuticals Corporation
$676
E.R. Squibb & Sons, L.L.C.
$658
SANOFI-AVENTIS U.S. LLC
$542
Incyte Corporation
$454
Pharmacyclics LLC, An AbbVie Company
$384
GENZYME CORPORATION
$304
Takeda Pharmaceuticals U.S.A., Inc.
$272
Celgene Corporation
$223
Kite Pharma, Inc.
$212
McKesson Specialty Care Distribution, LLC
$211
Clovis Oncology, Inc.
$199
Sirtex Medical Inc
$190
ABBVIE INC.
$189
Eisai Inc.
$183
Merck Sharp & Dohme Corporation
$177
TESARO, Inc.
$175
Blueprint Medicines Corporation
$168
ARRAY BIOPHARMA INC
$158
GlaxoSmithKline, LLC.
$153
Gilead Sciences, Inc.
$151
Merck Sharp & Dohme LLC
$145
Daiichi Sankyo Inc.
$144
AbbVie, Inc.
$119
Regeneron Healthcare Solutions, Inc.
$114
MorphoSys, US Inc.
$110
SEAGEN INC.
$100
Janssen Products, LP
$100
SERVIER PHARMACEUTICALS LLC
$77
JAZZ PHARMACEUTICALS INC.
$77
EISAI INC.
$73
Stemline Therapeutics Inc.
$69
SOBI, INC
$68
Sumitomo Pharma America, Inc.
$68
Mirati Therapeutics, Inc.
$65
Alexion Pharmaceuticals, Inc.
$61
Sobi, Inc
$60
Agios Pharmaceuticals, Inc.
$59
Coherus Biosciences Inc.
$59
PUMA BIOTECHNOLOGY, INC.
$56
US Oncology Corporate, Inc.
$54
Rigel Pharmaceuticals, Inc.
$53
EMD Serono, Inc.
$50
TAIHO ONCOLOGY, INC.
$50
Bayer Healthcare Pharmaceuticals Inc.
$50
AMAG Pharmaceuticals, Inc.
$48
BeiGene USA, Inc.
$48
Taiho Oncology, Inc.
$46
Myriad Genetic Laboratories, Inc.
$43
GE HealthCare
$42
Pharmacyclics LLC, an AbbVie Company
$39
Myovant Sciences Inc.
$35
Genmab U.S., Inc.
$27
Dova Pharmaceuticals
$26
Apellis Pharmaceuticals, Inc.
$26
Servier Pharmaceuticals LLC
$25
Boehringer Ingelheim Pharmaceuticals, Inc.
$24
ADC Therapeutics America, Inc.
$24
Spectrum Pharmaceuticals Inc.
$24
Array BioPharma Inc.
$24
Karyopharm Therapeutics Inc.
$24
Lilly USA, LLC
$24
AbbVie Inc.
$23
Fresenius Kabi USA, LLC
$22
SpringWorks Therapeutics, Inc.
$22
Foundation Medicine, Inc.
$22
Deciphera Pharmaceuticals Inc.
$20
Puma Biotechnology, Inc.
$20
Pharmacosmos Therapeutics Inc.
$19
Heron Therapeutics, Inc.
$19
NOVARTIS PHARMACEUTICALS CORPORATION
$19
PharmaEssentia USA Corporation
$19
SUN PHARMACEUTICAL INDUSTRIES INC.
$19
Organon LLC
$16
Aveo Pharmaceuticals, Inc.
$15
Fennec Pharmaceuticals, Inc.
$14
Exelixis Inc.
$14
MEDIVATION FIELD SOLUTIONS LLC
$14
Teva Pharmaceuticals USA, Inc.
$13
Top 3 companies account for 30.5% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AYVAKIT · Alecensa · Avastin · BAVENCIO · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Braftovi · CABOMETYX · CALQUENCE · CINVANTI · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELZONRIS · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · Enhertu · Entyvio · Epkinly · Erleada · FERAHEME · FOTIVDA · FRUZAQLA · Fabhalta · GAZYVA · GILOTRIF · Halaven · Herceptin · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · INVOKANA · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · Lupron · MEKINIST · MONJUVI · MONOFERRIC · MYCHOICE CDX · NINLARO · Nerlynx · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POLIVY · PROMACTA · PYRUKYND · Padcev · Pedmark · Perjeta · Phesgo · Polivy · Pomalyst · Prolia · QINLOCK · REBLOZYL · ROLVEDON · RYBREVANT · Revlimid · Rezlidhia · Rozlytrek · Rubraca · SARCLISA · SCEMBLIX · SIMPONI ARIA · SIR-Spheres Microspheres · STELARA · SUTENT · Stimufend · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · VARUBI · VELCADE · VENCLEXTA · VERZENIO · Vectibix · Venclexta · XGEVA · XPOVIO · XTANDI · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (64%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
86
Per 100K population
5.4
County median income
$88,724
Nearest hospital
MERCY HOSPITAL OF FOLSOM
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Javeed is a mixed practice specialist, with above-average Medicare volume (top 11% in CA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Javeed experienced with filgrastim injection (nivestym) for white blood cells?
Based on Medicare claims data, Dr. Javeed performed 41,100 filgrastim injection (nivestym) for white blood cells services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Javeed receive payments from pharmaceutical companies?
Yes. Dr. Javeed received a total of $16,496 from 85 companies across 616 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Javeed's costs compare to other hematology & oncology specialists in Folsom?
Dr. Javeed's average Medicare payment per service is $3. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Javeed) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Folsom
Browse hematology & oncology specialists in Folsom ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology